Good question. One you should ask Dr T in the other forum. he did say this (or something to this effect as it is not an exact quote).
My take is that the Israeli trial commenced before the newer more exciting discoveries of FTO, cardio and other synergistic effects for Zantrene that these newer programs will drive the long term value for RAC. Dr T did say the Israeli trial is "sitting on more of a traditional path" and doesn't really matter to the long term value of the company how the trial goes. But it is very useful and will provide a lot of interesting data.
RAC media coverage, page-862
-
- There are more pages in this discussion • 1,420 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
-0.095(5.44%) |
Mkt cap ! $281.0M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.62 | $285.9K | 170.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16759 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 12047 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |